DexCom, Inc. (DXCM)
91.04
-1.30
(-1.41%)
USD |
NASDAQ |
Aug 24, 16:00
91.52
+0.48
(+0.53%)
After-Hours: 20:00
DexCom EPS Diluted (Quarterly) : 0.6429 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.6429 |
| March 31, 2026 | 0.5109 |
| December 31, 2025 | 0.6761 |
| September 30, 2025 | 0.7035 |
| June 30, 2025 | 0.4476 |
| March 31, 2025 | 0.2658 |
| December 31, 2024 | 0.3799 |
| September 30, 2024 | 0.3352 |
| June 30, 2024 | 0.3512 |
| March 31, 2024 | 0.3583 |
| December 31, 2023 | 0.6235 |
| September 30, 2023 | 0.2898 |
| June 30, 2023 | 0.2774 |
| March 31, 2023 | 0.12 |
| December 31, 2022 | 0.2155 |
| September 30, 2022 | 0.2442 |
| June 30, 2022 | 0.1246 |
| March 31, 2022 | 0.2334 |
| December 31, 2021 | -0.0137 |
| September 30, 2021 | 0.2094 |
| June 30, 2021 | 0.1904 |
| March 31, 2021 | 0.1391 |
| December 31, 2020 | 0.8514 |
| September 30, 2020 | 0.1814 |
| June 30, 2020 | 0.1193 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.0529 |
| December 31, 2019 | 0.2497 |
| September 30, 2019 | 0.1238 |
| June 30, 2019 | -0.0288 |
| March 31, 2019 | -0.0745 |
| December 31, 2018 | -0.5065 |
| September 30, 2018 | 0.129 |
| June 30, 2018 | 0.0844 |
| March 31, 2018 | -0.0693 |
| December 31, 2017 | -0.0275 |
| September 30, 2017 | -0.005 |
| June 30, 2017 | 0.0075 |
| March 31, 2017 | -0.1225 |
| December 31, 2016 | -0.0225 |
| September 30, 2016 | -0.055 |
| June 30, 2016 | -0.06 |
| March 31, 2016 | -0.0575 |
| December 31, 2015 | 0.005 |
| September 30, 2015 | -0.1325 |
| June 30, 2015 | -0.0125 |
| March 31, 2015 | -0.0425 |
| December 31, 2014 | 0.005 |
| September 30, 2014 | -0.02 |
| June 30, 2014 | -0.0225 |
| March 31, 2014 | -0.0425 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Abbott Laboratories | 0.5324 |
| Insulet Corp. | 1.066 |
| Baxter International, Inc. | 0.2432 |
| Globus Medical, Inc. | 1.103 |
| Stryker Corp. | 3.306 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 249.10M |
| Revenue (Quarterly) | 1.308B |
| Total Expenses (Quarterly) | 1.059B |
| Enterprise Value | 34.30B |
| Gross Profit Margin (Quarterly) | 63.44% |
| Profit Margin (Quarterly) | 19.04% |
| Earnings Yield | 2.78% |
| Operating Earnings Yield | 3.15% |
| Normalized Earnings Yield | 2.783 |